article thumbnail

Factors Associated with Accumulating Diabetes Complications in a Medicare Advantage Cohort to Inform a Prediction Tool [Diabetes and endocrine disease]

Annals of Family Medicine

Context: Complications contribute to significant type 2 diabetes mellitus (T2DM) morbidity. Population Studied: Adults aged 65 years and older with T2DM enrolled in a national Medicare Advantage plan Setting or Dataset: Enrollment and claims data (2016-2020) Measures: The dependent variable was DCSI.

article thumbnail

Guideline Influence on PFO Identification and Stroke Prognosis

Physician's Weekly

They used linked administrative health records in Catalonia to explore all patients with ischemic stroke aged 18–60 from 2016 to 2021, collecting information on PFO diagnosis, demographics, comorbidities, stroke recurrence, and mortality. The results showed that 13,780 individuals experienced ischemic stroke, with a crude annual incidence of 30.3

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Identifying and Resolving Red Flags: DEA Continues to “Run it Up the Flagpole”

FDA Law Blog

DEA regulations state that a pharmacist has a corresponding responsibility not to fill a prescription unless it is issued for a “legitimate medical purpose by an individual practitioner acting in the usual course of [their] professional practice.” 12, 2012) (quoting Bob’s Pharmacy & Diabetic Supplies; Revocation of Registration, 74 Fed.

IT 40
article thumbnail

Drug Pricing Reform Gathers Steam (Part 1): White House Drug Pricing Plan Offers Laundry List of Existing Democrat Priorities

FDA Law Blog

Currently, individual Medicare Part D plan sponsors negotiate rebates but the government is explicitly prohibited from interfering in those negotiations. According to HHS, Medicare Part D could have saved as much as $3 billion in 2016 if generics were substituted for brand-name drugs wherever they were available.